Fertility preservation in pediatric leukemia and lymphoma: A report from the Children's Oncology Group

被引:7
|
作者
Close, Allison [1 ,9 ]
Burns, Karen [2 ]
Bjornard, Kari [3 ,4 ]
Webb, Martine [5 ]
Chavez, Josuah [6 ]
Chow, Eric J. [7 ]
Meacham, Lillian [8 ]
机构
[1] Michigan State Univ, Helen DeVos Childrens Hosp, Div Hematol Oncol, Coll Human Med, Grand Rapids, MI USA
[2] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Dept Pediat,Sch Med, Cincinnati, OH USA
[3] Indiana Univ Sch Med, Dept Pediat, Div Hematol Oncol, Indianapolis, IN USA
[4] Riley Hosp Children Indiana Univ Hlth, Indianapolis, IN USA
[5] Univ Calif Los Angeles, Div Internal Med, Los Angeles, CA USA
[6] Helen DeVos Childrens Hosp, Div Hematol Oncol, Grand Rapids, MI USA
[7] Seattle Childrens Hosp, Fred Hutchinson Canc Ctr, Seattle, WA USA
[8] Emory Univ Atlanta, Aflac Canc & Blood Disorders Ctr, Pediat Hematol Oncol BMT, Atlanta, GA USA
[9] Michigan State Univ, Helen DeVos Childrens Hosp, Coll Human Med, 100 Michigan St NE, Grand Rapids, MI 49503 USA
基金
美国国家卫生研究院;
关键词
fertility preservation; leukemia; lymphoma; oncofertility; YOUNG-ADULT CANCER; PREMATURE OVARIAN INSUFFICIENCY; GUIDELINE HARMONIZATION GROUP; ALKYLATING AGENT EXPOSURE; LONG-TERM SURVIVORS; CHILDHOOD-CANCER; TISSUE-TRANSPLANTATION; FEMALE SURVIVORS; ADOLESCENT; PREGNANCY;
D O I
10.1002/pbc.30407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Certain chemotherapy agents, radiation, and surgery can all negatively impact future fertility. Consults regarding treatment-related risk for infertility and gonadal late effects of these agents should occur at the time of diagnosis as well as during survivorship. Counseling on fertility risk has traditionally varied significantly across providers and institutions. We aim to provide a guide to standardize the assignment of gonadotoxic risk, which can be used in counseling patients both at the time of diagnosis and in survivorship. Gonadotoxic therapies were abstracted from 26 frontline Children's Oncology Group (COG) phase III protocols for leukemia/lymphoma, in use from 2000-2022. A stratification system based on gonadotoxic therapies, sex, and pubertal status was used to assign treatments into minimal, significant, and high level of increased risk for gonadal dysfunction/infertility. Risk levels were assigned to protocols and different treatment arms to aid oncologists and survivor care providers in counseling patients regarding treatment-related gonadotoxicity. Males were most commonly at high risk, with at least one high-risk arm in 14/26 protocols (54%), followed by pubertal females (23% of protocols) and prepubertal females (15% of protocols). All patients who received direct gonadal radiation or hematopoietic stem cell transplant (HSCT) were considered at high risk. Partnering with patients and their oncology/survivorship team is imperative for effective fertility counseling both prior to and post treatment, and this comprehensive guide can be used as a tool to standardize and improve reproductive health counseling in patients undergoing COG-based leukemia/lymphoma care.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Mentoring in Pediatric Oncology: A Report from the Children's Oncology Group Young Investigator Committee
    Levy, Adam S.
    Pyke-Grimm, Kimberly A.
    Lee, Dean A.
    Palla, Shana L.
    Naranjo, Arlene
    Sholler, Giselle Saulnier
    Gratias, Eric
    Maloney, Kelly
    Parshankar, Farzana
    Lee-Scott, Michelle
    Beierle, Elizabeth A.
    Gow, Kenneth
    Kim, Grace E.
    Hunger, Stephen
    Smith, Frank O.
    Horton, Terzah M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (06) : 456 - 461
  • [22] Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
    Loh, Mignon L.
    Zhang, Jinghui
    Harvey, Richard C.
    Roberts, Kathryn
    Payne-Turner, Debbie
    Kang, Huining
    Wu, Gang
    Chen, Xiang
    Becksfort, Jared
    Edmonson, Michael
    Buetow, Kenneth H.
    Carroll, William L.
    Chen, I-Ming
    Wood, Brent
    Borowitz, Michael J.
    Devidas, Meenakshi
    Gerhard, Daniela S.
    Bowman, Paul
    Larsen, Eric
    Winick, Naomi
    Raetz, Elizabeth
    Smith, Malcolm
    Downing, James R.
    Willman, Cheryl L.
    Mullighan, Charles G.
    Hunger, Stephen P.
    BLOOD, 2013, 121 (03) : 485 - 488
  • [23] The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report
    Lim, Megan S.
    Pulford, Karen
    Ait-Tahar, Kamel
    Patel, Suketu D.
    Kinney, Marsha C.
    Perkins, Sherrie L.
    Anderson, James R.
    Smith, Lynette
    Cairo, Mitchell S.
    Weitzman, Sheila
    Gross, Thomas G.
    Kraveka, Jacqueline M.
    BLOOD, 2010, 116 (21) : 1681 - 1681
  • [24] Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group
    W L Salzer
    M Devidas
    W L Carroll
    N Winick
    J Pullen
    S P Hunger
    B A Camitta
    Leukemia, 2010, 24 : 355 - 370
  • [25] Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report
    Vujkovic, Marijana
    Attiyeh, Edward F.
    Ries, Rhonda E.
    Goodman, Elizabeth K.
    Ding, Yang
    Kavcic, Marko
    Alonzo, Todd A.
    Wang, Yi-Cheng
    Gerbing, Robert B.
    Sung, Lillian
    Hirsch, Betsy
    Raimondi, Susana
    Gamis, Alan S.
    Meshinchi, Soheil
    Aplenc, Richard
    BLOOD, 2017, 129 (23) : 3051 - 3058
  • [26] PATIENT/FAMILY EDUCATIONAL PRACTICES IN PEDIATRIC ONCOLOGY: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG).
    Withycombe, Janice
    Andam-Mejia, Rachel
    Dwyer, Annie
    Windt, Katherine
    Slaven, Abigail
    Landier, Wendy
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E199 - E199
  • [27] Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group
    Marcotte, Erin L.
    Richardson, Michaela R.
    Roesler, Michelle A.
    Spector, Logan G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (04) : 473 - 478
  • [28] Current pediatric cancer survivorship practices: a report from the Children's Oncology Group
    Effinger, K. E.
    Haardorfer, R.
    Marchak, J. Gilleland
    Escoffery, C.
    Landier, W.
    Kommajosula, A.
    Hendershot, E.
    Sadak, K. T.
    Eshelman-Kent, D.
    Kinahan, K.
    Freyer, D. R.
    Chow, E. J.
    Mertens, A. C.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (04) : 1139 - 1148
  • [29] Current pediatric cancer survivorship practices: a report from the Children’s Oncology Group
    K. E. Effinger
    R. Haardörfer
    J. Gilleland Marchak
    C. Escoffery
    W. Landier
    A. Kommajosula
    E. Hendershot
    K. T. Sadak
    D. Eshelman-Kent
    K. Kinahan
    D. R. Freyer
    E. J. Chow
    A. C. Mertens
    Journal of Cancer Survivorship, 2023, 17 : 1139 - 1148
  • [30] Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group
    Chen, Shih-Hsiang
    Chen, Jiann-Shiuh
    Jou, Shiann-Tarng
    Wu, Kang-Hsi
    Hung, Iou-Jih
    Sheen, Jiunn-Ming
    Lu, Meng-Yao
    Chen, Bow-Wen
    Jaing, Tang-Her
    Wang, Shih-Chung
    Lin, Ming-Tsan
    Chang, Te-Kau
    Liu, Hsi-Che
    Yang, Chao-Ping
    LEUKEMIA & LYMPHOMA, 2019, 60 (08) : 1942 - 1949